Your browser doesn't support javascript.
loading
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma.
Khalil, Susanna; Fabbri, Enrica; Santangelo, Alessandra; Bezzerri, Valentino; Cantù, Cinzia; Di Gennaro, Gianfranco; Finotti, Alessia; Ghimenton, Claudio; Eccher, Albino; Dechecchi, Maria; Scarpa, Aldo; Hirshman, Brian; Chen, Clark; Ferracin, Manuela; Negrini, Massimo; Gambari, Roberto; Cabrini, Giulio.
Afiliação
  • Khalil S; Department of Pathology and Diagnostics, Laboratory of Molecular Pathology, University Hospital, Verona, Italy.
  • Fabbri E; Department of Life Sciences and Biotechnology, Section of Biochemistry and Molecular Biology, University of Ferrara, Ferrara, Italy.
  • Santangelo A; Department of Pathology and Diagnostics, Laboratory of Molecular Pathology, University Hospital, Verona, Italy.
  • Bezzerri V; Department of Pathology and Diagnostics, Laboratory of Molecular Pathology, University Hospital, Verona, Italy.
  • Cantù C; Department of Pathology and Diagnostics, Laboratory of Molecular Pathology, University Hospital, Verona, Italy.
  • Di Gennaro G; Department of Pathology and Diagnostics, Laboratory of Molecular Pathology, University Hospital, Verona, Italy.
  • Finotti A; Department of Life Sciences and Biotechnology, Section of Biochemistry and Molecular Biology, University of Ferrara, Ferrara, Italy.
  • Ghimenton C; Section of Pathology and Histology, University Hospital, Verona, Italy.
  • Eccher A; Section of Pathology and Histology, University Hospital, Verona, Italy.
  • Dechecchi M; Department of Pathology and Diagnostics, Laboratory of Molecular Pathology, University Hospital, Verona, Italy.
  • Scarpa A; Department of Pathology and Diagnostics, Laboratory of Molecular Pathology, University Hospital, Verona, Italy.
  • Hirshman B; Section of Pathology and Histology, University Hospital, Verona, Italy.
  • Chen C; Applied Research on Cancer Network (ARC-NET), University and Hospital Trust, Verona, Italy.
  • Ferracin M; Center for Theoretical and Applied Neuro-oncology, Moores Cancer Center, Department of Neurosurgery, University of California San Diego, San Diego, CA, USA.
  • Negrini M; Center for Theoretical and Applied Neuro-oncology, Moores Cancer Center, Department of Neurosurgery, University of California San Diego, San Diego, CA, USA.
  • Gambari R; Department of Morphology, Surgery and Experimental Medicine and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy.
  • Cabrini G; Department of Morphology, Surgery and Experimental Medicine and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy.
Oncotarget ; 7(19): 28195-206, 2016 May 10.
Article em En | MEDLINE | ID: mdl-27057640

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Metilases de Modificação do DNA / Regulação Neoplásica da Expressão Gênica / Glioblastoma / Proteínas Supressoras de Tumor / MicroRNAs / Enzimas Reparadoras do DNA Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Metilases de Modificação do DNA / Regulação Neoplásica da Expressão Gênica / Glioblastoma / Proteínas Supressoras de Tumor / MicroRNAs / Enzimas Reparadoras do DNA Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article